NUVB.WS VS CFRX Stock Comparison
Performance
NUVB.WS10/100
10/100
NUVB.WS returned -70.73% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
CFRX10/100
10/100
CFRX returned -98.02% in the last 12 months. Based on SPY's performance of 15.09%, its performance is below average giving it a score of 10 of 100.
Volatility
NUVB.WS64/100
64/100
NUVB.WS has had a higher than average amount of volatility over the last 12 months giving it a score of 64 of 100.
CFRX32/100
32/100
CFRX has had a lower than average amount of volatility over the last 12 months giving it a score of 32 of 100.
Analyst Price Targets
NUVB.WS
"Analyst Price Targets" not found for NUVB.WS
CFRX88/100
88/100
2 analysts offer 12-month price targets for CFRX. Together, they have an average target of 0, the most optimistic target put CFRX at 0 within 12-months and the most pessimistic has CFRX at 0.
Technicals
NUVB.WS
"Technicals" not found for NUVB.WS
CFRX14/100
14/100
CFRX receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
NUVB.WS
"Earnings" not found for NUVB.WS
CFRX10/100
10/100
CFRX has missed earnings 8 times in the last 20 quarters.
Profit
NUVB.WS
"Profit" not found for NUVB.WS
CFRX13/100
13/100
Out of the last 20 quarters, CFRX has had 3 profitable quarters and has increased their profits year over year on 1 of them.
All score calculations are broken down here to help you make more informed investing decisions
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 Summary
New York Stock Exchange / NUVB.WS
ContraFect Corporation Summary
Nasdaq / CFRX
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare NUVB.WS to other companies in the same or a similar industry.